title: Scleritis.
authors.affiliation: a Department of Ophthalmology , California Pacific Medical Center , San Francisco , California , USA .|b The Department of Ophthalmology , Stanford University School of Medicine , Stanford , California , USA .|c The Francis I. Proctor Foundation, UCSF School of Medicine , San Francisco , California , USA .
authors.forename: Emmett T
authors.initials: ET
authors.lastname: Cunningham
authors.affiliation: d Save Sight Institute, Sydney Medical School, University of Sydney , NSW , Australia .
authors.forename: Peter
authors.initials: P
authors.lastname: McCluskey
authors.affiliation: e Moorfields Eye Hospital and Biomedical Research Centre, NHS Foundation Trust , London , UK .
authors.forename: Carlos
authors.initials: C
authors.lastname: Pavesio
authors.affiliation: f Faculty of Medicine , University of New South Wales , Kensington , Sydney , New South Wales , Australia , and.
authors.forename: Denis
authors.initials: D
authors.lastname: Wakefield
authors.affiliation: g Centre for Ophthalmology, University Tuebingen , Tuebingen , Germany.
authors.forename: Manfred
authors.initials: M
authors.lastname: Zierhut
mesh_terms: D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D005260:Female; D005480:Flurbiprofen / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D015423:Scleritis / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D016861:Cyclooxygenase Inhibitors; D005480:Flurbiprofen